| 4.88 0.65 (15.37%) | 01-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.09 | 1-year : | 7.11 |
| Resists | First : | 5.21 | Second : | 6.09 |
| Pivot price | 3.95 |
|||
| Supports | First : | 3.66 | Second : | 2.7 |
| MAs | MA(5) : | 4.59 |
MA(20) : | 3.72 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 74.5 |
D(3) : | 73.9 |
| RSI | RSI(14): 64 |
|||
| 52-week | High : | 26.5 | Low : | 2.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TTRX ] has closed below upper band by 19.6%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 4.95 - 4.98 | 4.98 - 5 |
| Low: | 4.19 - 4.21 | 4.21 - 4.23 |
| Close: | 4.84 - 4.88 | 4.88 - 4.92 |
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Mon, 12 Jan 2026
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates - TipRanks
Mon, 12 Jan 2026
Turn Therapeutics Inc Announces Corporate and Pipeline Updates for 2026 - TradingView — Track All Markets
Mon, 12 Jan 2026
Eczema drug trial and nasal flu vaccine set key 2026 milestones - Stock Titan
Fri, 09 Jan 2026
Turn Therapeutics Reaches US$132m Market Cap Benefiting Insider Stock Buying - Sahm
Thu, 08 Jan 2026
Turn Therapeutics Reaches US$132m Market Cap Benefiting Insider Stock Buying - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 1.049e+007 (%) |
| Held by Institutions | 64.3 (%) |
| Shares Short | 54 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -3.94e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -78.7 % |
| Return on Equity (ttm) | -2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 24350 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|